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Abstract: PZP and GnRH immunocontraceptive vaccines were each tested in white-tailed deer 
(Odocoileus virginianus) . Vaccination with PZP produced reversible infertility lasting 1 to 4 years. 
The first two years of active immunization resulted in an 89% reduction in fawning. Reduction in 
fawning for the 7-year study containing 4 years of no boosting was 72%. PZP immunization 
resulted in multi-estrus behavior, with contracepted deer returning to estrus up to 7 times. A five 
year study of GnRH immunization was conducted in both male and female deer. Treatment of 
does led to reduced fawning rates, reduced estrus behavior and reduced concentrations of 
progesterone. During active immunization GnRH does bred to untreated bucks had an 88% 
reduction in fawning caused by either immunocontraception or immunocontragestion. Reduction 
in fawning for the 5 year study containing 2 years of no boosting was 74%. The vaccine effect was 
reversible and directly related to the antibody titer. Infertility lasted up to two years without 
boosting. GnRH immunized bucks had no interest in sexual activity when paired with control 
females. Depending on the immunization schedule, antlers either dropped early or remained in 
velvet. 
Key words: immunocontraceptive vaccine, Odocoileus virginianus, white-tailed deer 
Introduction 
A growing interest in nonlethal 
methods for population control of nuisance or 
damaging species of wildlife has fostered 
research in reducing fertility of these pest 
wildlife species. Fertility may be reduced by 
interfering with the fertilization of the egg 
(Contraception) or interfering with the 
implantation or development of the fertilized 
egg (Contragestion) (Miller et al. 1998). 
Reproduction can be blocked at many 
sites in the reproductive process (Figure 1). 
Two contraceptive vaccines discussed in this 
paper are PZP and GnRH. 
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The zona pellucida (ZP) is an acellular 
glycoprotein layer surrounding the 
mammalian oocyte ( egg). During fertilization, 
sperm must bind to zona pellucida receptors 
on the outer surface of the oocyte and 
penetrate the ZP for conception to take place 
(Miller 2000a). Immunization with PZP 
inhibits fertilization. Native porcine zona 
pellucida (PZP) vaccines have been used to 
produce sterilization in horses, burros , deer , 
baboons and other species (Kirpatrick et al. 
1990; Garrott et al. 1992; Turner 1996a, 
1996b; Miller 1999b ). 
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Figure 1. Mammalian Reproductive 
Endocrinology; showing blocking sites of the 
2 immunocontraceptive vaccines ( GnRH and 
PZP) presented in this paper. 
GnRH is a small peptide hormone that 
is not naturally immunogenic, but can be 
made immunogenic by coupling it to a carrier 
such as keyhole limpet hemocyanin (KLH). 
GnRH antibodies bind to endogenous GnRH 
and prevent the release of FSH and LH (Ferro 
et al.1996; Ferro and Stimson 1998). 
The reduction or absence of serum 
FSH and LH leads to atrophy of the gonads 
leading to infertility in both sexes. The 
immunoneutralization of GnRH through the 
use of GnRH vaccines appears to be highly 
specific, and does not appear to affect other 
hypothalamic releasing hormones; Awoniyi et 
al. (1993) demonstrated that GnRH 
immunized rats failed to release FSH and LH, 
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but that other pituitary hormones and their 
vital non-sexual functions were not impaired. 
GnRH contraceptive vaccines have 
been evaluated as immunocastration agents in 
pets, cattle, sheep, swine and deer ( Ladd et al. 
1994; Adams and Adams 1992; Schanbacher 
1998; Meloen et al. 1994; Oonk et al. 1998; 
and Miller et al. 2000b) 
Recently, in studies with the Norway 
rat (Miller et al. 1997a), we found that both 
males and females immunized with a GnRH 
vaccine were 100% infertile. 
Methods and materials 
This study was conducted at the Deer 
Research Center of The Pennsylvania State 
University, University Park, PA. Deer were 
kept in a 17 acre wooded enclosure and 
provided hay and pellets ad libitum. During 
handling, deer were restrained mechanically 
and chemically with 0.5 to 1.0 ml of xylazine . 
PZP vaccine 
Deer were immunized with purified 
porcine zona pellucida (PZP) which was 
prepared by and purchased from Dr. Dunbar 
at the Baylor College of Medicine, Houston, 
TX. Eleven deer were injected with 1 ml of 
PZP vaccine distributed subcutaneously and 
intradermally among several sites above the 
vertebrae of the back between the scapulae. 
The I ml prime dose consisted of 0 .5 ml of 
saline containing 500 µg of PZP mixed with 
0.5 ml of complete Freund's adjuvant (CFA). 
The booster doses contained 300 µg PZP in 
0.5 ml saline mixed with 0.5 ml of incomplete 
Freund's adjuvant (IFA). Eight control deer 
were sham injected with saline mixed I: 1 as 
above with CFA in the prime dose or IFA in 
each boost dose . 
All of the PZP treated deer were 
immunized the first year, 8 of 11 were boosted 
the second year, and 4 of 9 deer were boosted 
the third year. None of the deer were boosted 
after the third year. The decision to boost deer 
in the 2nd or 3rd years was determined by the 
antibody titer. Those deer that appeared to 
have a rapidly dropping antibody titer in the 
previous year were boosted. 
GnRH Vaccine 
The 10 amino acid GnRH peptide 
hormone which is conserved among all 
mammals was made immunogenic by 
coupling the peptide to KLH, a large protein 
containing numerous T cell epitopes. The 
GnRH used in this study was synthesized at 
Macromolecular Resources, Colorado State 
University (Ft. Collins, CO) with the structure 
rpEHWSYGLRPGGC-SH]. A glycine was 
added at the C terminus as a spacer and a 
cysteine was added to ensure consistent 
alignment of the peptide to the maleimide 
activated protein carrier KLH. The underlined 
amino acids represent the native GnRH 
molecule (Miller et al. 2000b). 
In a 5 year study on the effectiveness 
of KLH-GnRH vaccine to immunocontracept 
deer, eight fertile does and 4 fertile bucks 
were injected subcutaneously with one 
primary immunization followed later by 
booster doses all containing 1 ml of vaccine 
distributed among several sites at the center of 
the back between the scapulae. All deer 
received a prime dose containing 500 µg of 
KLH-GnRH in saline mixed I: I with 
complete Freund's adjuvant (CFA) and 
approximately one month later were given a 
boost containing 300 µg of KLH-GnRH 
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mixed I: 1 with incomplete Freund's adjuvant 
(IFA). Boost injections were given on a 
yearly basis depending on the current antibody 
titer. Fawning results of the GnRH treated 
does were compared to the fawning rates of 
sham treated does and fawning of the does 
from the herd not involved in the study (Miller 
et al. 2000b). 
Laboratory studies 
In both the PZP and GnRH studies, 
jugular blood samples were taken immediately 
before the prime injection and each boost and 
several times after the vaccinations. 
Following clotting, samples were centrifuged 
at 1000 x g. Serum was harvested and 
samples were stored at -20 °es C. for 
subsequent ELISA, progesterone or 
testosterone assays. 
Observations on mating, gestation and 
fawning 
To determine when the does were in 
estrus for both the PZP and GnRH vaccines, 
behavioral observations of the bucks toward 
the treated does were made by Penn State 
University students three times daily from 
November 7 through February 12 and then 
two times daily until February 28. Behavioral 
activity by the buck included sniffing or 
pursuit of the female, aggressive guarding, and 
mounting and copulation. 
Trans-rectal ultrasound was performed 
in late January or early February, and 
abdominal palpation was performed in late 
March or early April. Blood was drawn the 
day of the ultrasound and tested for 
progesterone concentration. 
From May through August, does were 
observed daily for evidence of fawning. 
Observations on behavioral estrus were used 
to estimate the date of conception. Ultrasound 
observations were used to confirm that does 
were in the first trimester of gestation. 
Abdominal palpation was used to confirm that 
does were in the last trimester of gestation. 
PZP results 
Fawning 
During the first 3 years, when there 
was active immunization, 11 treated deer 
produced 6 fawns, compared with 56 fawns 
from the same number of control does, or an 
89% reduction in fawning (P < 0.01). For all 
7 years (Table 1 ), including 4 years when deer 
were not boosted, 25 fawns were born to the 
PZP treated does compared with 103 fawns 
born to the same number of control does, or a 
72% reduction in fawning (P < 0.01) . The 
sham injected does had a normal fawning rate 
similar to the control herd (P > 0.05). 
The length of time that the deer 
remained infertile after they were given a 
vaccine boost ranged from 1 to 4 years. There 
was a direct correlation between reduced 
fawning and antibody titer. As antibody titers 
dropped and deer regained fertility most does 
had only l fawn, which was born at late as 
August or September. As the deer regained 
fertility they could be reboosted and the 
infertility could last for several years after the 
boost. 
Behavioral observations 
Most control deer in the study were 
bred at the first observed estrus, and breeding 
was completed during the month of November. 
One or two estrus events were observed on 
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average for each control doe during the 
breeding period lasting 44 days. During the 
first three years of active immunization, PZP 
treated does were observed to have one to four 
sexual encounters per doe (mean =3.6), and 
remain sexually active over 98 days. Several 
does exhibited sexual activity in January and 
February. For all 6 years, including years when 
fertility was regained by some of the does, the 
mean number of estrus events in the PZP 
treated deer was 2.4 . One doe was observed 
with 7 cycles of sexual activity, with the last 
observed activity occurring on March 4. This 
doe was sexually active for 150 days but 
remained infertile. 
Progesterone levels 
During the normal breeding season of 
October to December, control deer had serum 
progesterone concentrations of ~4.0 ng/ml at 
some time during each month representing 
ovulation. There appeared to be some 
synchronization of the estrus activity and 
elevated progesterone levels in the control herd . 
Progesterone concentrations of ~4 ng/ml in late 
January to early February generally correlated 
with fawning in the control deer. The 4.0 ng/ml 
progesterone in the PZP did not correlate with 
pregnancy since the PZP antibody could protect 
the ovulated egg from sperm penetration . 
Ultrasound and palpation 
Ultrasound has been shown to be an 
excellent predictor of early pregnancy In 
control animals and the PZP treated does, a 
positive ultrasound observation in late January 
or early February, and a positive abdominal 
palpation in April or May were predictive of 
fawning. 
Table 1. Fawning data of the PZP treated deer as compared to the Sham controls and the breeding Herd 
at The Pennsyvania State University, University Park, PA. 
Yearly Cumulative 
Year Treatment Fawns/Does Average Average 
92-93 Primed & Boosted 4/11 .36 .36 
93-94 Boosted 1/11 .09 .23 
94-95 4/9 Boosted 1/9 .11 .19 
95-96 None Boosted 3/9 .33 .23 
96-97 None Boosted 7/9 .78 .33 
97-98 None Boosted 9/8 1.13 .44 
98-99 None Boosted 8/7 1.14 .52 
Breeding herd 156/90 1.73 
Sham controls 1.84 
PZP treated .52 
A reduction in fawns of 89% was achieved during active immunization , 
and a 72 % reduction in fawns was seen over seven years including four 
years without boosting. 
GnRH results 
Female deer 
Fawning Data. A reduction in fawns of 
88% was achieved during active immunization, 
and a 74% reduction in fawns was observed 
over five years including two years without 
boosting (Table 2). 
Five fawns were born to the 4 does 
during the 4 years, or 5 fawns/14 doe years ( doe 
years the number of does times the number 
years tested), compared to 25 fawns/14 doe 
years in the control deer during this same period 
of time. 
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Of the four additional does given GnRH 
treatment in the third year, one fawn was born 
during the first year. With the additional group 
of does added there were 6 fawns/22 doe years 
(0.27 fawns/doe/year) as compared with 40 
fawns/22 doe years (1.8 fawns/doe/year) in the 
control group . This represents an 88% 
reduction ( P<0 .01) in fawning in the GnRH 
group compared with the controls. The average 
of 1.83 fawns/doe/year among the control does 
in the study is representative of the normal 
breeding herd average at PSU . Fawns born to 
the GnRH treated deer appeared healthy and 
normal. 
Table 2. Fawning data of the GnRH treated deer as compared to the Sham controls and the breeding 
herd at The Pennsyvania State University, University Park, PA 
Year Treatment 
94-95 Primed & boosted 
95-96 Primed & boosted 
96-97 Boosted 
97-98 No boost 
98-99 No boost 
Breeding herd 
Sham controls 
GnRH treated 
Fawns/Does 
3/4 
0/6 
1/8 
3/8 
9/9 
156/90 (x=l.7) 
35/19 (x= 1.8) 
16/35 (x=.46) 
A reduction in fawns of 88% was achieved during active immunization, 
and a 74% reduction in fawns was seen over five years including two years 
without boosting . 
Behavioral observations. Under 
normal situation, deer are asexual for the 
majority of the year. The short day lengths of 
the autumn tum on the sexual activity for the 
short breeding season. Some of the GnRH 
treated deer never develop this seasonal sexual 
activity and remained asexual throughout the 
breeding season . Although progesterone data 
indicated that the does were not cycling, there is 
some activity from the bucks, ranging from 
sniffing the does to short pursuits of bucks 
chasing does. The limited amount of estrus 
activity in the GnRH treated does was observed 
over 30 days. The observed estrus events for 
the control does were typically 1 or 2 per doe 
over a total period of 44 days. 
65 
Male deer 
Control bucks in our study had serum 
testosterone concentrations of less than 100 
ng/100 ml late summer and early fall and 
developed normal breeding levels of 
testosterone (350 to > 400 ng/100 ml) in 
October. Peak breeding activity occurred in 
November when bucks were introduced to 
does. Antlers grew slowly early in the summer 
but rapid growth ensued in August and 
September. Antlers remained in velvet until 
September at which time the velvet was rubbed 
off on nearby trees. Antlers dropped off in 
March of the following year. The bucks in the 
GnRH group were treated the first year with a 
prime dose in September and boosts in 
October. They lost their already hardened 
antlers two weeks after the second boost 
(between October 20 to 28). Their testes were 
less then one half the size of normal bucks, and 
they did not develop the prominent neck 
musculature normally observed in the autumn 
on mature bucks and therefore looked very 
much like a doe throughout the breeding 
season. Treated bucks were penned with 
untreated cycling does but demonstrated little 
sexual interest in the does. Serum testosterone 
levels for the GnRH-treated bucks ranged from 
11-74 ng/100 ml throughout the breeding 
season, which were in the range of levels 
during the non-breeding period. 
In the second year, three of the bucks 
were boosted with the KLH-GnRH vaccine in 
July and August. The fourth buck died before 
the start of the second year of research. The 
anti-GnRH titers peaked in September. The 
testosterone of these bucks remained less than 
30 ng/100 ml throughout the breeding season. 
In contrast to the first year, the antlers remained 
in velvet throughout the fall. The antlers never 
cleaved normally at the base of the pedicel, but 
instead broke off 1 to 4 inches above the 
pedicel between January 10 and February 13. 
This breakage was likely a result of freezing 
temperatures killing the unhardened antler, 
thereby resulting in reduced antler strength. 
The sexual responses of the bucks were 
directly related to the anti-GnRH titers 
throughout the three years . When GnRH 
treated bucks were put in the same pen with 
control cycling females they demonstrated no 
sexual interest in the does that were in estrous. 
At the same time the GnRH treated bucks were 
casually eating next to the doe in estrus, the 
fertile buck in the next paddock was trying to 
break down the fence. Three out of the four 
bucks returned to fertility in 2 years; however, 
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1 buck remained infertile with regressed 
testicles (even though the antibody titer had 
dropped) until he died several years later. 
Discussion 
Both the PZP and GnRH vaccines have 
advantages and disadvantages. Both vaccines 
change the behavior of the deer in reproductive 
season. The PZP vaccine induced infertility in 
does is associated with increased sexual activity 
for an extended period, as evidenced by an 
average increase in the number of estrous 
cycles observed per doe. Although the multiple 
estrous cycles observed with PZP-treated does 
have been reported by others (Turner et al. 
1992), the present study clearly demonstrates 
that if the PZP antibody titer drops to an 
unprotecting level late in the breeding season, 
conception may occur resulting in fawns born 
in August or September, which places them at 
considerable risk for winter survival. The 
increased duration of the rutting season may 
increase deer-car collisions because of the 
restlessness of the herd. In our study, the 
control herd majority had become pregnant in 
44 days, but the PZP treated deer were still 
cycling after this period. There is little or no 
observable difference in the appearance of the 
PZP treated deer as compared to the control 
does. 
The does treated with the GnRH 
vaccine have a reduced level of estrus activity. 
The GnRH treated bucks have little sexual 
interest in the control does, and the effects of 
reduced testosterone in the bucks either causes 
the antlers to drop off in the fall the year of 
treatment or remain in velvet in the succeeding 
years. 
The GnRH vaccine has potential as a 
management technique that could control 
population size as well as reduce deer 
movements during rutting season, thereby 
reducing deer/car collisions. Additionally, the 
vaccine could reduce the aggressiveness of a 
"pet buck" in a park setting during the fall 
rutting season. 
Although both PZP and GnRH 
demonstrate potential as contraceptives, 
improved delivery methods still need more 
research (Miller 1997 b; Miller et al. 1999a) In 
addition to the immunocontraceptive 
technology, research in other methods of 
interrupting reproduction to control population 
of various pest species need more research 
(Miller and Fagerstone 2000) 
Conclusion 
Both vaccines are effective in reducing 
the fertility of white-tailed deer. In PZP 
immunocontracepted deer, fertility was reduced 
as much as 89% during active immunization, 
and for the entire 7-year study, with 4 years of 
no immunization, was reduced by 72%. PZP 
immunization stimulates high antibody titers 
that can reduce fertility for one to four years 
without boosting. Thereafter, as anti-PZP titers 
declined, doe fertility was restored, but at a 
reduced fawning rate . Previously infertile does 
that regained fertility were again made infertile 
by a single boost before the next breeding 
season. The prolonged contraceptive effects of 
the PZP vaccine are desirable aspects as an 
agent for deer population control. However, 
these benefits should be weighed against the 
extended breeding season and late fawning 
associated with its use . 
The GnRH vaccine is effective during 
active immunization in reducing fawning rates 
by 88% . After 2 years of no immunization the 
overall reduction in fawning for the 5 years was 
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74%. The GnRH conjugate produced high 
antibody titers resulting in infertility for up to 
two years without boosting. It appears that this 
vaccine is reversible; that is, when the antibody 
titer drops, fertility is restored. Furthermore, 
the deer could be boosted again causing the 
deer to again become infertile. There was little 
difference in the observed behavioral effects 
between the GnRH treated does and the control 
does. GnRH treated bucks, on the other hand, 
lost most sexual interest in the does coming 
into estrus. Early antler loss and the absence of 
antler hardening may be considered negative 
side effects of treating bucks. 
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